{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:57:34Z","timestamp":1785430654068,"version":"3.56.0"},"reference-count":61,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012141","name":"China Institute of Atomic Energy","doi-asserted-by":"publisher","award":["YD040270325091"],"award-info":[{"award-number":["YD040270325091"]}],"id":[{"id":"10.13039\/501100012141","id-type":"DOI","asserted-by":"publisher"}]},{"award":["YD040270325091"],"award-info":[{"award-number":["YD040270325091"]}],"id":[{"id":"https:\/\/ror.org\/00v5gqm66","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nanomaterials"],"abstract":"<jats:p>Boron Neutron Capture Therapy (BNCT), as a promising oncological modality, enables the specific therapy of tumor cells while minimizing damage to healthy tissues. It has emerged as a critical strategy for combating refractory malignancies such as glioma, breast cancer, lung cancer, and hepatocellular carcinoma. The development of efficient boron carriers is fundamental to realizing the clinical potential of BNCT. This review systematically traces the evolutionary trajectory of boron carriers, from first-generation soluble borates and second-generation agents to third-generation actively targeted formulations, with a particular focus on the current state of nanoparticle-based carriers. It provides a detailed analysis of the structural properties, boron-loading advantages, targeting modification strategies, and key research findings associated with various nanoplatforms, including liposomes, polymers, dendrimers, boron carbide nanoparticles, and gold nanoparticles. Furthermore, by examining specific tumor cell targets such as folate receptors and integrin receptors, the review elucidates the mechanisms by which nanocarriers achieve tumor boron enrichment through both the enhanced permeability and retention (EPR) effect and ligand-mediated active targeting. The review also critically assesses current challenges in the field, including targeting efficacy, boron loading capacity, in vivo retention, and biocompatibility. Finally, it summarizes emerging strategies\u2014such as multi-target modification, combination immunotherapy, theranostics, and the induction of tumor cell pyroptosis\u2014and provides a forward-looking perspective on future developments, aiming to inform the rational design of next-generation BNCT boron carriers with high targeting specificity, high boron payload, and low toxicity.<\/jats:p>","DOI":"10.3390\/nano16140845","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:16:44Z","timestamp":1783613804000},"page":"845","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanoparticle Boron Carrier for Boron Neutron Capture Therapy: Research Progress and Perspectives in China"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2470-3559","authenticated-orcid":false,"given":"Haozhan","family":"Xie","sequence":"first","affiliation":[{"name":"China Institute of Atomic Energy, Beijing 102413, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyun","family":"Fan","sequence":"additional","affiliation":[{"name":"China Institute of Atomic Energy, Beijing 102413, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1606-7765","authenticated-orcid":false,"given":"Fenglin","family":"Li","sequence":"additional","affiliation":[{"name":"China Institute of Atomic Energy, Beijing 102413, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"ref_1","first-page":"203","article-title":"Cancer survival statistics in China 2019\u20132021: A multicenter, population-based study","volume":"4","author":"Zeng","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hosmane, N.S., A Maguire, J., Zhu, Y., and Takagaki, M. (2011). Boron and Gadolinium Neutron Capture Therapy for Cancer Treatment, World Scientific Pub Co Pte Ltd.","DOI":"10.1142\/8056"},{"key":"ref_3","first-page":"2635","article-title":"High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: Therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab\u2019 fragments in a human colonic cancer model","volume":"59","author":"Behr","year":"1999","journal-title":"Cancer Res."},{"key":"ref_4","first-page":"679","article-title":"Comparative analysis of cancer incidence and mortality between developed and devel-oping countries","volume":"39","author":"Wang","year":"2012","journal-title":"Chin. J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ar7000815","article-title":"Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases","volume":"41","author":"Low","year":"2007","journal-title":"Acc. Chem. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11671-008-9210-9","article-title":"Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy","volume":"4","author":"Ciofani","year":"2008","journal-title":"Nanoscale Res. Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.apradiso.2011.05.002","article-title":"Design, development and characterization of multi-functionalized gold nanoparticles for biodetection and targeted boron delivery in BNCT applications","volume":"69","author":"Mandal","year":"2011","journal-title":"Appl. Radiat. Isot."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.2147\/OTT.S169555","article-title":"RGD-modified nanoliposomes containing quercetin for lung cancer targeted treatment","volume":"11","author":"Zhou","year":"2018","journal-title":"OncoTargets Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Amin, M., Mansourian, M., Burgers, P.C., Amin, B., Jaafari, M.R., and Hagen, T.L.M.T. (2022). Increased Targeting Area in Tumors by Dual-Ligand Modification of Liposomes with RGD and TAT Peptides. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14020458"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jmgm.2012.05.006","article-title":"Early stage intercalation of doxorubicin to DNA fragments observed in molecular dynamics binding simulations","volume":"38","author":"Lei","year":"2012","journal-title":"J. Mol. Graph. Model."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jrr\/rrt098","article-title":"Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer","volume":"55","author":"Suzuki","year":"2013","journal-title":"J. Radiat. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/scientificamerican1090-100","article-title":"Boron Neutron Capture Therapy for Cancer","volume":"263","author":"Barth","year":"1990","journal-title":"Sci. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1360\/TB-2021-1013","article-title":"Boron delivery agents for boron neutron capture therapy","volume":"67","author":"Li","year":"2021","journal-title":"Chin. Sci. Bull."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1126\/science.128.3338.1572.a","article-title":"Salt Excretion by Nasal Gland of Laysan and Black-Footed Albatrosses","volume":"128","author":"Frings","year":"1958","journal-title":"Science"},{"key":"ref_15","first-page":"279","article-title":"Neutron capture therapy with boron in the treatment of glioblastoma multiforme","volume":"71","author":"Sweet","year":"1954","journal-title":"Am. J. Roentgenol. Radium Ther. Nucl. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/ja01537a021","article-title":"Synthesis of Aromatic Boronic Acids. Aldehydo Boronic Acids and a Boronic Acid Analog of Tyrosine1","volume":"80","author":"Snyder","year":"1958","journal-title":"J. Am. Chem. Soc."},{"key":"ref_17","first-page":"251","article-title":"First human clinical trial of melanoma neutron capture. Diagnosis and therapy","volume":"165","author":"Mishima","year":"1989","journal-title":"Strahlenther. Onkol."},{"key":"ref_18","first-page":"127","article-title":"Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides","volume":"165","author":"Yoshino","year":"1989","journal-title":"Strahlenther. Onkol."},{"key":"ref_19","first-page":"163","article-title":"Spectrophotometric determination of BPA content in biological tissues","volume":"26","author":"Li","year":"2013","journal-title":"J. Isot."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/jm00316a042","article-title":"Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron Compounds","volume":"10","author":"Soloway","year":"1967","journal-title":"J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00314601","article-title":"A revised boron-neutron capture therapy for malignant brain tumors","volume":"209","author":"Hatanaka","year":"1975","journal-title":"J. Neurol."},{"key":"ref_22","first-page":"164","article-title":"Acute toxicity and pharmacokinetics of disodium dodecaborate sulfhydrate","volume":"29","author":"Li","year":"2016","journal-title":"J. Isot."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"43387","DOI":"10.1021\/acsami.8b14682","article-title":"Tracing Boron with Fluorescence and Positron Emission Tomography Imaging of Boronated Porphyrin Nanocomplex for Imaging-Guided Boron Neutron Capture Therapy","volume":"10","author":"Shi","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101558","DOI":"10.1016\/j.nantod.2022.101558","article-title":"Multifunctional high boron content MOFs nano-co-crystals for precise boron neutron capture therapy for brain glioma in situ","volume":"45","author":"Wang","year":"2022","journal-title":"Nano Today"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3835(00)00717-5","article-title":"Competitive uptake of porphyrin and LDL via the LDL receptor in glioma cell lines: Flow cytometric analysis","volume":"166","author":"Shibata","year":"2001","journal-title":"Cancer Lett."},{"key":"ref_26","first-page":"11","article-title":"Research progress of novel lipid nanoparticles in antitumor drugs","volume":"23","author":"Dong","year":"2025","journal-title":"J. Clin. Pharmacother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11060-008-9522-8","article-title":"Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: A modality for boron neutron capture therapy","volume":"87","author":"Doi","year":"2008","journal-title":"J. Neuro-Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1021\/bc0100713","article-title":"Development of EGF-Conjugated Liposomes for Targeted Delivery of Boronated DNA-Binding Agents","volume":"13","author":"Kullberg","year":"2002","journal-title":"Bioconjugate Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/bjc.1991.124","article-title":"Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model","volume":"63","author":"Tomita","year":"1991","journal-title":"Br. J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12951-022-01304-0","article-title":"Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma","volume":"20","author":"Chen","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2020401118","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s13205-020-2132-7","article-title":"Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapy","volume":"10","author":"Baskararaj","year":"2020","journal-title":"3 Biotech"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1039\/D4CS00891J","article-title":"Engineered multi-domain lipid nanoparticles for targeted delivery","volume":"54","author":"Liu","year":"2025","journal-title":"Chem. Soc. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"38865","DOI":"10.1021\/jacs.5c14870","article-title":"Computationally Aided Design of Ionizable Cholesteryl Lipids for Lipid Nanoparticles to Modulate Hepatic mRNA Accumulation","volume":"147","author":"Teng","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2536802","DOI":"10.1080\/10717544.2025.2536802","article-title":"Enhancing targeted delivery and efficacy of PEGylated liposomal doxorubicin with liposomal minoxidil: Comprehensive in silico, in vitro, and in vivo tumor model studies","volume":"32","author":"Mohammadzadeh","year":"2025","journal-title":"Drug Deliv."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"52474","DOI":"10.1021\/acsami.5c11509","article-title":"Dual-Functional Nanoliposome with High BPA Loading for Targeted MRI-Guided BNCT of Glioblastoma","volume":"17","author":"Qin","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/IJN.S14912","article-title":"Recent advances in PEG\u2013PLA block copolymer nanoparticles","volume":"5","author":"Zeng","year":"2010","journal-title":"Int. J. Nanomed."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/187152006776119135","article-title":"Recent Progress in the Syntheses and Biological Evaluation of Boronated Porphyrins for Boron Neutron-Capture Therapy","volume":"6","author":"Renner","year":"2006","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Glaskova-Kuzmina, T., Starkova, O., Gaidukovs, S., Platnieks, O., and Gaidukova, G. (2021). Durability of Biodegradable Polymer Nanocomposites. Polymers, 13.","DOI":"10.3390\/polym13193375"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1021\/bc950077q","article-title":"Boronated Epidermal Growth Factor as a Potential Targeting Agent for Boron Neutron Capture Therapy of Brain Tumors","volume":"7","author":"Capala","year":"1996","journal-title":"Bioconjugate Chem."},{"key":"ref_41","first-page":"845","article-title":"Biological mechanisms and clinical research progress of boron neutron capture therapy","volume":"43","author":"Chen","year":"2023","journal-title":"Chin. J. Radiol. Med. Prot."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/1535-7163.MCT-05-0161","article-title":"Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature","volume":"4","author":"Backer","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"ref_43","first-page":"1744","article-title":"Research progress and clinical application of boron delivery agents in boron neutron cap-ture therapy","volume":"31","author":"Su","year":"2023","journal-title":"J. Mod. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17458080.2019.1692178","article-title":"A method to selectively internalise submicrometer boron carbide particles into cancer cells using surface transferrin conjugation for developing a new boron neutron capture therapy agent","volume":"15","author":"Tsuji","year":"2019","journal-title":"J. Exp. Nanosci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Pulagam, K.R., Gona, K.B., G\u00f3mez-Vallejo, V., Meijer, J., Zilberfain, C., Estrela-Lopis, I., Baz, Z., Coss\u00edo, U., and Llop, J. (2019). Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In Vivo Evaluation. Molecules, 24.","DOI":"10.3390\/molecules24193609"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"110387","DOI":"10.1016\/j.colsurfb.2019.110387","article-title":"Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT)","volume":"183","author":"Wu","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1111\/cas.16298","article-title":"Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron immunotherapy (B-NIT)","volume":"115","author":"Fujimoto","year":"2024","journal-title":"Cancer Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1039\/D5TB00478K","article-title":"Lyophilized tumour cell-loaded 10B-doped carbon dots for simultaneous boron neutron capture therapy and enhancement of antitumor immunity of prostate cancer","volume":"13","author":"Yang","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"ref_49","first-page":"487","article-title":"Application and development of tumor-targeted boron delivery agents in boron neutron cap-ture therapy","volume":"45","author":"Chen","year":"2023","journal-title":"J. Nucl. Radiochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biomaterials.2015.03.061","article-title":"Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model","volume":"56","author":"Iguchi","year":"2015","journal-title":"Biomaterials"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.biomaterials.2016.06.046","article-title":"Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects","volume":"104","author":"Gao","year":"2016","journal-title":"Biomaterials"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"120587","DOI":"10.1016\/j.biomaterials.2020.120587","article-title":"A Boron-10 nitride nanosheet for combinational boron neutron capture therapy and chemotherapy of tumor","volume":"268","author":"Li","year":"2021","journal-title":"Biomaterials"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-020-2079-1","article-title":"A bioorthogonal system reveals antitumour immune function of pyroptosis","volume":"579","author":"Wang","year":"2020","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ijrobp.2025.04.026","article-title":"Unveiling Cellular Responses and Underlying Immune Effects Induced by Boron Neutron Capture Therapy","volume":"123","author":"Mao","year":"2025","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41467-025-67984-y","article-title":"Boron neutron capture therapy preserves immune cells and induces robust anti-tumour immunity in preclinical mouse model","volume":"17","author":"Sun","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Basak, S. (2026). AI and Machine Learning for Proteomics-Driven Drug Discovery: Methods, Tools, and Best Practices. Curr. Issues Mol. Biol., 48.","DOI":"10.3390\/cimb48050532"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"217448","DOI":"10.1016\/j.ccr.2025.217448","article-title":"Recent advances in coordination chemistry on the application and development of radiopharmaceuticals and boron neutron capture therapy","volume":"551","author":"Cai","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Zhou, R., You, Z., and Liu, L. (2025). Boron neutron capture therapy in the context of tumor heterogeneity: Progress, challenges, and future perspectives. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1601013"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Imperio, D., Postuma, I., Villani, S., Del Grosso, E., Cansolino, L., Ferrari, C., Fallarini, S., Bortolussi, S., and Panza, L. (2025). A Novel Closo-Ortho-Carborane-Based Glucosamine Derivative as a Promising Agent for Boron Neutron Capture Therapy. Pharmaceuticals, 18.","DOI":"10.3390\/ph18070986"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Palmieri, M.A., Hughes, A.M., Trivillin, V.A., Garabalino, M.A., Ramos, P.S., Thorp, S.I., Curotto, P., Pozzi, E.C.C., Mart\u00ednez, M.N., and Teixidor, F. (2024). Cobaltabis(Dicarbollide) [o-COSAN]\u2212 for Boron Neutron Capture Therapy of Head and Neck Cancer: Biodistribution and Irradiation Studies in an Experimental Oral Cancer Model. Pharmaceuticals, 17.","DOI":"10.3390\/ph17101367"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"112044","DOI":"10.1016\/j.apradiso.2025.112044","article-title":"Boron nanodrugs for boron neutron capture therapy","volume":"225","author":"Wan","year":"2025","journal-title":"Appl. Radiat. Isot."}],"container-title":["Nanomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-4991\/16\/14\/845\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T04:13:12Z","timestamp":1783915992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-4991\/16\/14\/845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":61,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["nano16140845"],"URL":"https:\/\/doi.org\/10.3390\/nano16140845","relation":{},"ISSN":["2079-4991"],"issn-type":[{"value":"2079-4991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}